---
title: "Dawnrays Pharma drops 3% in Hong Kong trading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305918134.md"
description: "Dawnrays Pharma fell 2.75% to HK$0.8850. Down 2.75% over five sessions and down 23.51% YTD."
datetime: "2026-11-18T05:31:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305918134.md)
  - [en](https://longbridge.com/en/news/305918134.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305918134.md)
generator: "portal-rs"
---

# Dawnrays Pharma drops 3% in Hong Kong trading

Dawnrays Pharma (2348.HK) declined nearly **3%** in Hong Kong trading, last at **HK$0.8850**.

The stock is down 2.75% over the past five sessions and down 23.51% year to date. It sits 25.44% below its 52-week high of HK$1.187. Volume was 3.97 times its average.

The Hang Seng Index is down 4.20% over the past five sessions and down 9.11% year to date.

The pharmaceuticals industry index fell 1.7% over the same period, in line with the stock's move.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [02348.HK](https://longbridge.com/en/quote/02348.HK.md)

## Related News & Research

- [Dawnrays Pharmaceutical Discloses Share Buyback in HKEX Next-Day Return](https://longbridge.com/en/news/305794886.md)
- [Dawnrays Pharmaceutical Reports Share Buyback in HKEX Next Day Disclosure Return](https://longbridge.com/en/news/302536211.md)
- [GIGABYTE Concludes AI Partner Summit, Showcasing Real-World AI Agent Solutions for Enterprise](https://longbridge.com/en/news/306311368.md)
- [AI tech rout prompts US investors to rush into value stocks](https://longbridge.com/en/news/306321872.md)
- [Key facts: SK hynix results surge; Kioxia stake rises; HYAICO formed](https://longbridge.com/en/news/306338337.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**